Canada · Delayed Price · Currency is CAD Amgen Statistics
Total Valuation
Amgen has a market cap or net worth of CAD 309.51 billion. The enterprise value is 371.11 billion.
| Market Cap | 309.51B |
| Enterprise Value | 371.11B |
Important Dates
The next estimated earnings date is Thursday, November 5, 2026.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | Aug 21, 2026 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.46% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.17% |
| Owned by Institutions (%) | 83.74% |
| Float | 539.16M |
Valuation Ratios
The trailing PE ratio is 24.93 and the forward PE ratio is 16.99.
| PE Ratio | 24.93 |
| Forward PE | 16.99 |
| PS Ratio | 5.72 |
| PB Ratio | 18.65 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 21.42 |
| P/OCF Ratio | 17.47 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.89, with an EV/FCF ratio of 25.68.
| EV / Earnings | 29.89 |
| EV / Sales | 6.85 |
| EV / EBITDA | 14.89 |
| EV / EBIT | 20.51 |
| EV / FCF | 25.68 |
Financial Position
The company has a current ratio of 1.37, with a Debt / Equity ratio of 4.90.
| Current Ratio | 1.37 |
| Quick Ratio | 0.95 |
| Debt / Equity | 4.90 |
| Debt / EBITDA | 3.27 |
| Debt / FCF | 5.63 |
| Interest Coverage | 4.14 |
Financial Efficiency
Return on equity (ROE) is 91.47% and return on invested capital (ROIC) is 19.76%.
| Return on Equity (ROE) | 91.47% |
| Return on Assets (ROA) | 8.67% |
| Return on Invested Capital (ROIC) | 19.76% |
| Return on Capital Employed (ROCE) | 18.14% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 1.72M |
| Profits Per Employee | 394,157 |
| Employee Count | 31,500 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 1.67 |
Taxes
In the past 12 months, Amgen has paid 2.19 billion in taxes.
| Income Tax | 2.19B |
| Effective Tax Rate | 15.01% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 30.20 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 47.13 |
| Average Volume (20 Days) | 4,285 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.16 |
Income Statement
In the last 12 months, Amgen had revenue of CAD 54.10 billion and earned 12.42 billion in profits. Earnings per share was 22.86.
| Revenue | 54.10B |
| Gross Profit | 38.89B |
| Operating Income | 18.07B |
| Pretax Income | 14.61B |
| Net Income | 12.42B |
| EBITDA | 24.52B |
| EBIT | 18.07B |
| Earnings Per Share (EPS) | 22.86 |
Balance Sheet
The company has 19.87 billion in cash and 81.38 billion in debt, with a net cash position of -61.51 billion.
| Cash & Cash Equivalents | 19.87B |
| Total Debt | 81.38B |
| Net Cash | -61.51B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 16.60B |
| Book Value Per Share | 30.70 |
| Working Capital | 13.43B |
Cash Flow
In the last 12 months, operating cash flow was 17.72 billion and capital expenditures -3.27 billion, giving a free cash flow of 14.45 billion.
| Operating Cash Flow | 17.72B |
| Capital Expenditures | -3.27B |
| Depreciation & Amortization | 6.45B |
| Net Borrowing | 1.87B |
| Free Cash Flow | 14.45B |
| FCF Per Share | n/a |
Margins
Gross margin is 71.89%, with operating and profit margins of 33.40% and 22.95%.
| Gross Margin | 71.89% |
| Operating Margin | 33.40% |
| Pretax Margin | 27.00% |
| Profit Margin | 22.95% |
| EBITDA Margin | 45.33% |
| EBIT Margin | 33.40% |
| FCF Margin | 26.70% |
Dividends & Yields
This stock pays an annual dividend of 0.74, which amounts to a dividend yield of 2.48%.
| Dividend Per Share | 0.74 |
| Dividend Yield | 2.48% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 60.45% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.46% |
| Shareholder Yield | 2.02% |
| Earnings Yield | 4.01% |
| FCF Yield | 4.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Amgen has an Altman Z-Score of 1.89 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.89 |
| Piotroski F-Score | 8 |